Linkopings Universitet

6 trials 4 recruiting Academic / non-commercial

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

2 Completed trials

1 Countries active

10 Unique IMPs

100% Results reported

Phase II

Phase I/II

Phase I (Other)

Phase II: 4 Phase I/II: 1 Phase I (Other): 1

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

SODIUM CHLORIDE 2 BUPRENORPHINE 1 BUPRENORPHINE, NALOXONE 1 DARIDOREXANT 1 DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL 1 LENOMORELIN 1 MORPHINE HYDROCHLORIDE 1 OXYTOCIN 1

All trials

6 total

Examining the effects of intravenous oxytocin infusion on peripheral sensory afferents using microneurography technique in healthy volunteer… Recruiting

2024-519670-39-00 Phase I (Other) 1 country OXYTOCIN
A Phase I/II Double-blind, randomized, placebo-controlled trial to preserve residual insulin secretion in children with recent onset Type 1 … Recruiting

2024-515106-30-00 Phase I/II 1 country
A double-blind, randomized, controlled trial on the effect of PEX010 for prolonged grief disorder Recruiting

2024-518218-24-00 Phase II 1 country DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL
The dual orexin receptor antagonist daridorexant as an adjunct to improve buprenorphine maintenance therapy of opioid use disorder Recruiting

2024-517482-16-00 Phase II 1 country BUPRENORPHINE; BUPRENORPHINE, NALOXONE; DARIDOREXANT
Morphine effects on stress response and social interaction – an exploratory randomized controlled experimental medicine study Ended

2024-517855-10-00 Phase II 1 country MORPHINE HYDROCHLORIDE; SODIUM CHLORIDE
Effects of the appetite-inducing hormone ghrelin on decision making in healthy volunteers Ended

2024-517598-26-00 Phase II 1 country LENOMORELIN; SODIUM CHLORIDE

Showing 1–6 of 6 trials

← All sponsors A–Z